A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.
US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy: Tokyo Friday, February 14, 2025, 09:00 Hrs [IST] Astellas Pharma Inc., a global lif ...
The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results